With a focus on life science, the group drives growth through a buy-and-build strategy, targeting scalable businesses in assistive tech, medtech, and specialty pharma. Strong financial performance is supported by organic growth, acquisitions, and a clear market focus.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.